ARC logo.png
Biodefense Market Value Anticipated To Reach US$ 19.1 Billion By 2027: Acumen Research And Consulting
March 31, 2021 13:06 ET | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Biodefense Market– Global Industry Analysis, Market Size, Opportunities and...
CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) Published in Science Translational Medicine
January 07, 2021 06:00 ET | CytoDel Inc
Studies Show Cyto-111 Enables Delivery of Antibodies to Previously Inaccessible Intraneuronal Targets without the need for a Viral Vector or Transfection Supports the Development of New Approaches to...
Biodefense Market by Type and Application - Global Industry Analysis and Forecast To 2022
November 21, 2017 06:49 ET | Crystal Market Research
LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- The latest trending report published by Crystal Market Research titled, Biodefense Market, approximates that the Biodefense Market size is estimated to...
PositiveID Corporation Announces 2015 Highlights and 2016 Outlook
January 11, 2016 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., Jan. 11, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today...
PositiveID Corporation to Present at the SeeThruEquity Microcap Healthcare Investor Conference on January 11, 2016
January 05, 2016 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., Jan. 05, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences tools and diagnostics company, announced today that its...
PositiveID Corporation Meets Major Development Milestone: New Firefly Dx Prototype With Real-Time Optics for Pathogen Detection
October 12, 2015 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., Oct. 12, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced...
PositiveID Corporation to Present at the Aegis Capital Corp. 2015 Growth Conference on October 8th
September 29, 2015 08:30 ET | PositiveID Corporation
DELRAY BEACH, Fla., Sept. 29, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced...
Battelle National Biodefense Institute Awarded 10-Year National Biodefense Analysis and Countermeasures Center Contract
September 23, 2015 10:22 ET | Battelle
FREDERICK, MD--(Marketwired - September 23, 2015) - The Battelle National Biodefense Institute has been awarded a new 10-year management and operations contract for the National Biodefense Analysis...
AIMLogo.jpg
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Collaborate on Alferon(R) and Ampligen(R) Against the Ebola Virus
November 03, 2014 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has been informed by USAMRIID scientists that they have in-vitro data...
AIMLogo.jpg
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Agree to Collaborate in Studying Alferon(R) and Ampligen(R) Against the Ebola Virus
September 08, 2014 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 8, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that the Company and USAMRIID scientists have agreed to test...